Bio-Rad Laboratories, Inc. (BIO) News

Bio-Rad Laboratories, Inc. (BIO): $797.34

11.70 (+1.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BIO News Items

BIO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BIO News Highlights

  • For BIO, its 30 day story count is now at 92.
  • Over the past 27 days, BIO's stories per day has been in a clear downtrend, falling by about 0.29 per day.
  • The most mentioned tickers in articles about BIO are RAD, CLDX and BODY.

Latest BIO News From Around the Web

Below are the latest news stories about Bio-Rad Laboratories Inc that investors may wish to consider to help them evaluate BIO as an investment opportunity.

Legionella Testing Market Future Outlook 2027 with Beckman Coulter Diagnostics, Bio-Rad Laboratories, Abbott, Roche Diagnostics Europe,

Legionella Testing Market size is anticipated to reach substantial + 9.1 % CAGR during the forecast period 2021-2027. Legionella is a bacteria that causes Legionnaires disease, often known as flu-like illness, which is a serious type of pneumonia. Legionella testing reveals

OpenPR | September 20, 2021

Gene Expression Analysis Market current and future demand 2027 with top leading players like Thermo Fisher Scientific, Qiagen, Illumina, Bio-Rad Laboratories, F. Hoffmann-La Roche

Gene Expression Analysis Market forecast to 2027 The Global Gene Expression Analysis Market report provides information about the Global industry, including valuable facts and figures. This research study explores the Global Market in detail such as industry chain structures, raw material suppliers, with manufacturing The Gene Expression Analysis Sales market examines the primary segments of []

Cheshire Media | September 20, 2021

Global STD Diagnostics Market by Current Industry Status, Growth Opportunities, Top Key Players, and Forecast till 2030 | Abbott Laboratories, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Cellabs, Cepheid

According to new informative report by Absolute Markets Insights an analytical data of STD Diagnostics market has recently added to its massive database. The research report is encapsulate different verticals of the businesses. It has been aggregated on the basis

OpenPR | September 19, 2021

Unexpected Growth Seen in Global Molecular Diagnostics Market as it May Reach US$ 16359.76+ Million by 2030| Key Players: Roche Diagnostics, Abbott, Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Bayer AG

The Global Molecular Diagnostics Market Research Report by Absolute Markets Insights is an inclusive coverage of drivers, trends, analysis, opportunities, and restraints of the landscape. The study aims to offer a key in-road for potential investors to understand the growth

OpenPR | September 18, 2021

10 Healthcare Stocks to Buy According to Mario Gabelli

In this article, we discuss the 10 healthcare stocks to buy according to Mario Gabelli. If you want to skip our detailed analysis of these stocks, go directly to the 5 Healthcare Stocks to Buy According to Mario Gabelli. Veteran investor Mario Gabelli is now almost 80-years-old with an incredibly long and successful career on […]

Yahoo | September 18, 2021

POC Diagnostics Market worth USD 81.37 Billion at 9.4% by 2028 Backed by Increasing Investment in Development of POC Kits in Europe, reports Fortune Business Insights

Key Prominent Players Covered in the POC Diagnostics Market Research Report Are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics Incorporated, BD, bioMérieux SA, Cardinal Health, Inc., Cepheid, Trinity Biotech, Quidel Corporation, Bio-Rad Laboratories Inc, Other Players Key Prominent Players Covered in the POC Diagnostics Market Research Report Are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics Incorporated, BD, bioMérieux SA, Cardinal Health, Inc., Cepheid, Trinity Biotech, Quidel Corporation, Bio-Rad Laboratories Inc, Other Players

Intrado Digital Media | September 16, 2021

Bio-Rad (BIO) Upgraded to Strong Buy: Here's Why

Bio-Rad (BIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Yahoo | September 16, 2021

Hematology Oncology Market Future Outlook: Top Companies, Abbott, Bio-Rad Laboratories, Danaher Corporation, AstraZeneca

Hematology is the study of blood and bone marrow illnesses, as well as their diagnosis, prevention, and therapy. Oncology is the branch of medicine that deals with the prevention, treatment, and diagnosis of cancer. Hematology is used in a variety

OpenPR | September 15, 2021

Bio-Rad Laboratories (BIO) Is Up 0.05% in One Week: What You Should Know

Does Bio-Rad Laboratories (BIO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Yahoo | September 14, 2021

Europe Genomics Market Explosive Boom US$ 15,448 Mn by 2021-28 with Illumina, Inc, Danaher, F. HOFFMANN-LA ROCHE LTD, BIO-RAD LABORATORIES INC, General Electric Company

The Europe Genomics Market is expected to reach US$ 15,448 million, to reach at a CAGR of +12% from 2021-2028. Genomics is the study of whole genomes of organisms, and incorporates elements from genetics. Genomics uses a combination of recombinant DNA,

OpenPR | September 13, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6663 seconds.